Skip to main content
OpenTrials
Completed

NCT Number: NCT03519282

Clinical Evaluation of Investigational Multifocal Toric Contact Lenses

This non-dispensing study is to evaluate the clinical performance of a test multifocal toric silicone hydrogel contact lens compared to a marketed multifocal toric contact lens (control).

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Eurolens Research

Manchester, M13 9PL, United Kingdom

About this study

This non-dispensing study is to evaluate the clinical performance of a test multifocal toric silicone hydrogel contact lens compared to a marketed multifocal toric contact lens (control).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Has had a self-reported oculo-visual examination in the last two years.
  • Is aged 40-75 years, inclusive and has full legal capacity to volunteer.
  • Has read and understood the participant information sheet.
  • Is willing and able to follow instructions and maintain the appointment schedule.
  • Is able to participate in Parts A and B related to this work.
  • Has a contact lens spherical prescription between +10.00 to -10.00D (inclusive).
  • Has an Add component to their spectacle refraction (between +0.75 and +2.50DS).
  • Has astigmatism between -0.75 and -5.75DC (based on the vertexed ocular refraction in each eye.
  • Can be satisfactorily fitted with the study lenses.
  • Is correctable to a visual acuity of 20/40 (0.30 logMAR) or better (in each eye) with their habitual vision correction or 20/25 (0.10 logMAR) best-corrected.
  • They have successfully worn soft contact lenses in the last six months
  • Has clear corneas and no active ocular disease.
  • Has not worn lenses for at least 12 hours before the examination.
  • Has an up-to-date pair of spectacles.

Exclusion criteria

  • Has never worn contact lenses before.
  • Has any systemic disease affecting ocular health.
  • Is using any systemic or topical medications that will affect ocular health.
  • Has any ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would, in the opinion of the investigator, affect the wearing of contact lenses.
  • Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye that would, in the opinion of the investigator, be problematic for their participation in the study.
  • Has any clinically significant lid or conjunctival abnormalities, active neovascularization or any central corneal scars.
  • Is aphakic.
  • Has undergone corneal refractive surgery.
  • Has a history of anaphylaxis or severe allergic reaction.
  • Has diabetes or an infectious or immunosuppressive disease which could contraindicate contact lens wear or pose a risk to the investigator.
  • They are pregnant or breast-feeding.
  • Is participating in any other type of eye-related clinical or research study.

Treatment and study plan

comfilcon A Multifocal Toric lens

Device

contact lens

Other names: Test Multifocal Toric Lens, Biofinity multifocal toric lens

omafilcon A Multifocal Toric Lens

Device

contact lens

Other names: Proclear multifocal toric lens, Control multifocal toric lens

Primary outcomes

  1. Visual Acuity

    Time frame: Up to 2 hours

    Visual Acuity (measured in LogMAR)

Secondary outcomes

  1. Assessment of Visual Performance: Distance Navigation Tasks for Vision Quality and Clarity

    Time frame: Up to 2 hours

    Subjective assessment of visual performance for distance navigation tasks for vision quality and clarity was assessed on a scale 0-100, 0=poor, 100=excellent.

  2. Assessment of Visual Performance: Intermediate Task for Vision Quality and Clarity

    Time frame: Up to 2 hours

    Subjective assessment of visual performance for intermediate task for vision quality and clarity was assessed on a scale 0-100, 0=poor, 100=excellent.

  3. Assessment of Visual Performance: Near Task for Vision Quality and Clarity

    Time frame: Up to 2 hours

    Subjective assessment of visual performance for near task for vision quality and clarity was assessed on a scale 0-100, 0=poor, 100=excellent.

Sponsors and collaborators

Lead sponsor

CooperVision, Inc.

Industry

Registry information

Official study title

Clinical Evaluation of Biofinity Multifocal Toric Contact Lenses

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
May 8, 2018
Registry last updated
May 4, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.